Evidence map›Paper›PMID 33371071›Full record

ArticleMedicine2020

Expression of lipoma preferred partner in mammary and extramammary Paget disease.

Ye Liu, Yangbin Wang, Ruiqun Qi, Xiaoyun Mao, Feng Jin

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ye LiuDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University.ORCID 0000-0002-1965-5926
Yangbin WangDepartment of Dermatology, The First Hospital of China Medical University, Heping District, Shenyang, Liaoning Province, P.R. China.
Ruiqun QiDepartment of Dermatology, The First Hospital of China Medical University, Heping District, Shenyang, Liaoning Province, P.R. China.
Xiaoyun MaoDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University.
Feng JinDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

national science foundation of China 81972791Science and Technology Plan Project of Liaoning Province 2013225585
6 · The paper itself

Abstract

backgoundThis study aims to identify the expression of lipoma preferred partner (LPP) in Paget disease (PD) and to further understand the pathogenesis of PD.

methodsTissue microarray was used to evaluate the expression of LPP by immunohistochemistry in 40 PD patients. The results of LPP expression were combined with clinical and histopathological characteristics. Patient files were analyzed retrospectively.

resultsTwenty-one cases were mammary Paget disease (MPD) and 19 extramammary Paget disease (EMPD) involving the vulva, scrotum, and penis. LPP was expressed in PD and this expression was significantly greater in MPD versus EMPD (P = .031). The expression of LPP in MPD was significantly related with age (P = .009) and expression of Ki-67 (P = .011). No statistically significant differences were observed in LPP expression as related to sex, body location, and time of PD diagnosis.

conclusionsWhile LPP is expressed in both MPD and EMPD, the intensity of this expression is greater in MPD. LPP expression is positively correlated with Ki-67 and is more prevalent in middle-aged versus senior MPD patients. Further research is needed to determine its potential role in tumorigenesis and distribution.

Indexed as

AdultAgedAged, 80 and overAge FactorsBreast NeoplasmsCytoskeletal ProteinsFemaleHumansLIM Domain ProteinsMaleMiddle AgedNeoplasmsPaget Disease, ExtramammaryPaget's Disease, MammaryPenile NeoplasmsRetrospective StudiesCytoskeletal ProteinsLIM Domain ProteinsLPP protein, human

Identifiers

PMID33371071
PMCPMC7748372
OpenAlexW3111940520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.